Impact of bevacizumab-based chemotherapy on outcomes of liver resections in colorectal metastases: Results from a propensity matched analysis - Université de Rennes Accéder directement au contenu
Article Dans Une Revue HPB Année : 2016

Impact of bevacizumab-based chemotherapy on outcomes of liver resections in colorectal metastases: Results from a propensity matched analysis

Résumé

no abstract

Dates et versions

hal-01310760 , version 1 (03-05-2016)

Identifiants

Citer

Y. Mouchel, L. Sulpice, D. Bergeat, M. Rayar, C. Pery, et al.. Impact of bevacizumab-based chemotherapy on outcomes of liver resections in colorectal metastases: Results from a propensity matched analysis. HPB, 2016, Abstracts of the 11th International Congress of the European-African Hepato-Pancreato-Biliary Association, 21-24 April 2015, Manchester, UK, 18, Supplement 2, pp.e698. ⟨10.1016/j.hpb.2016.01.098⟩. ⟨hal-01310760⟩
44 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More